Global Perspectives in Gastrointestinal Malignancies (WCGI)
Latest therapeutic developments in GI cancer treatment and implications on individualized clinical decision-making. How will emerging data shape future treatment paradigms?
Faculty Chair
Howard S. Hochster, MD, FACP
Rutgers Cancer Institute of New Jersey
Faculty Members
Dirk Arnold, MD, PhD
University of Hamburg, Germany
Dominik Modest, MD
University of Munich, Germany
Gerald Prager, MD, PhD
University of Vienna, Austria
Julien Taieb, MD, PhD
University of Paris, France
Efrat Dotan, MD
Fox Chase Cancer Center, Philadelphia, PA, USA
Tanios Bekaii-Saab, MD, FACP
Mayo Clinic Cancer Center, Phoenix, AZ, USA
Scott Kopetz, MD, PhD, FACP
MD Anderson Cancer Center, Houston, TX, USA
Christopher Lieu, MD
University of Colorado Cancer Center, Aurora, CO, USA
REPORT TOPICS INCLUDE
- Metastatic Colorectal Cancer – Chemotherapy, Targeted Therapies, and Biomarker-Driven Treatments
- Metastatic Colorectal Cancer – Immunotherapy
- Rectal Cancer
- Gastroesophageal Junction (GEJ) and Gastric Cancer
- Hepatocellular Carcinoma (HCC)
- Pancreatic Cancer and Biliary Tract Cancer
